Jilin Aodong Pharmaceutical Group Co Ltd (000623) — Cash Flow Quality Index
Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a Cash Flow Quality Index of 0.11x as of September 2025. Operating cash flow of CN¥112.12 Million is below net income of CN¥978.96 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 000623 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Jilin Aodong Pharmaceutical Group Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) cash flow conversion.
Annual Cash Flow Quality Index for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Jilin Aodong Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥272.26 Million | CN¥2.40 Billion | ▲ +190.3% |
| 2024 | 0.04x | CN¥59.48 Million | CN¥1.52 Billion | ▼ -16.0% |
| 2023 | 0.05x | CN¥68.06 Million | CN¥1.46 Billion | ▼ -80.4% |
| 2022 | 0.24x | CN¥423.86 Million | CN¥1.78 Billion | ▲ +30.5% |
| 2021 | 0.18x | CN¥324.85 Million | CN¥1.78 Billion | ▼ -20.1% |
| 2020 | 0.23x | CN¥390.41 Million | CN¥1.71 Billion | ▼ -16.1% |
| 2019 | 0.27x | CN¥379.46 Million | CN¥1.39 Billion | ▼ -26.7% |
| 2018 | 0.37x | CN¥347.64 Million | CN¥935.19 Million | ▲ +167.4% |
| 2017 | 0.14x | CN¥256.49 Million | CN¥1.85 Billion | ▼ -30.6% |
| 2016 | 0.20x | CN¥333.81 Million | CN¥1.67 Billion | ▲ +34.3% |
| 2015 | 0.15x | CN¥388.03 Million | CN¥2.60 Billion | ▼ -26.8% |
| 2014 | 0.20x | CN¥288.83 Million | CN¥1.42 Billion | ▲ +7.5% |
| 2013 | 0.19x | CN¥201.22 Million | CN¥1.06 Billion | ▼ -54.8% |
| 2012 | 0.42x | CN¥272.40 Million | CN¥649.87 Million | ▲ +667.5% |
| 2011 | 0.05x | CN¥108.30 Million | CN¥1.98 Billion | ▼ -60.6% |
| 2010 | 0.14x | CN¥174.22 Million | CN¥1.26 Billion | ▼ -9.7% |
| 2009 | 0.15x | CN¥213.03 Million | CN¥1.39 Billion | ▼ -42.0% |
| 2008 | 0.27x | CN¥235.03 Million | CN¥886.21 Million | ▲ +38.0% |
| 2007 | 0.19x | CN¥384.69 Million | CN¥2.00 Billion | ▼ -59.2% |
| 2006 | 0.47x | CN¥187.99 Million | CN¥399.47 Million | ▼ -53.8% |
| 2005 | 1.02x | CN¥136.26 Million | CN¥133.76 Million | ▼ -27.7% |
| 2004 | 1.41x | CN¥218.53 Million | CN¥155.11 Million | ▲ +15.1% |
| 2003 | 1.22x | CN¥147.65 Million | CN¥120.67 Million | ▲ +2472.1% |
| 2002 | -0.05x | CN¥-4.58 Million | CN¥88.71 Million | ▼ -103.1% |
| 2001 | 1.69x | CN¥138.76 Million | CN¥82.07 Million | ▲ +91.8% |
| 2000 | 0.88x | CN¥77.04 Million | CN¥87.40 Million | ▼ -19.7% |
| 1999 | 1.10x | CN¥110.18 Million | CN¥100.32 Million | ▲ +419.3% |
| 1998 | -0.34x | CN¥-30.90 Million | CN¥89.82 Million | — |